LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Metrics to compare | LNSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLNSRPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.0x | −3.7x | −0.6x | |
PEG Ratio | 0.02 | −0.20 | 0.00 | |
Price/Book | −6.5x | 2.9x | 2.6x | |
Price / LTM Sales | 2.6x | 3.6x | 3.3x | |
Upside (Analyst Target) | 18.5% | 26.2% | 39.0% | |
Fair Value Upside | Unlock | −0.9% | 4.9% | Unlock |